Close
ACHEMA MIDDLE EAST 2026

Fresh Biologics Clinical Manufacturing CDMO Service Trends

In the ever-changing pharma and biologics sector, the Biologics Clinical Manufacturing CDMO Service market has gone on to emerge as quite a prominent player...

CDMOs Using Specialized Solutions To Meet Cold Chain Needs

It is worth noting that the Cell and gene therapies- CGTs have gone on to show immense promise when it comes to treating diverse...

The After-Effects of A Poor Laboratory Inventory Management

Inventory management happens to be simultaneously the most essential and, at the same time, the most disliked task that laboratorians carry out on a...

Four Ways To Creating Better Flexible Lab Design Space

Life science companies happen to be facing either a rapid expansion or a consolidation because of the fluctuations in market conditions, the requirement to...

Drug Delivery Innovations Boosting Women-Health All The More

Right from elevating the contraceptive methods to going ahead and improving the treatment of reproductive health issues, drug delivery innovations happen to be paving...

Drug Delivery Innovation & Peptide-Stabilized Emulsions

A new study which has been led by Prof. Meital Reches from the Hebrew University, along with Mr. Daniel Boas, one of the Ph.D....

New Molecular Device Opens Door To Targeted Drug Delivery

In one of the newly brought up breakthroughs that could go ahead and even revolutionize medical as well as material engineering, scientists have gone...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...